|$243,332||To analyze the Georgia Medicaid program?s new payment models for contraceptive access||2020 - 2022||LJAF|
|$181,083||To examine how prescription drugs can be developed by a nonprofit company.||2020 - 2022||LJAF|
|$300,000||To examine key factors that impact the availability of long acting reversible contraceptive methods at Federally Qualified Health Centers and disseminating key findings.||2018 - 2019||LJAF|
Have an evidence-based week
Get The Abstract from Arnold Ventures delivered to your inbox.